{
    "organizations": [],
    "uuid": "424d6166bd54d430295fabd899a73386c75a4b18",
    "author": "cnbc.com",
    "url": "http://www.cnbc.com/2018/03/26/globe-newswire-sol-gel-technologies-ltd-availability-of-its-annual-report-on-form-20-f-through-its-website.html",
    "ord_in_thread": 0,
    "title": "Sol-Gel Technologies Ltd. Availability of Its Annual Report on Form 20-F Through Its Website",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "NESS ZIONA, Israel, March 26, 2018 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (NASDAQ:SLGL), a clinical-stage dermatology company, announced today that it filed its Annual Report for 2017 on Form 20-F, containing audited financial statements for the year ended December 31, 2017, as filed with the Commission on March 26, 2018, which is available on its website ( http://www.sol-gel.com ). Shareholders may receive a hard copy of the annual report free of charge upon request.\nAbout Sol-Gel Technologies\nSol-Gel is a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Sol-Gelâ€™s current product candidate pipeline consists of late-stage branded product candidates that leverage our proprietary, silica-based microencapsulation technology platform, and several generic product candidates across multiple indications.\nFor further information, please contact:\nSol-Gel Contact:\nGilad Mamlok\nChief Financial Officer\n+972-8-9313433\nInvestor Contact:\nPatricia L. Bank\nWestwicke Partners\n+1-415-513-1284\npatti.bank@westwicke.com\nSource:Sol-Gel Technologies Ltd.",
    "published": "2018-03-27T00:05:00.000+03:00",
    "crawled": "2018-03-27T01:27:47.001+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "ness",
        "ziona",
        "israel",
        "march",
        "globe",
        "newswire",
        "technology",
        "nasdaq",
        "slgl",
        "dermatology",
        "company",
        "announced",
        "today",
        "filed",
        "annual",
        "report",
        "form",
        "containing",
        "audited",
        "financial",
        "statement",
        "year",
        "ended",
        "december",
        "filed",
        "commission",
        "march",
        "available",
        "website",
        "http",
        "shareholder",
        "may",
        "receive",
        "hard",
        "copy",
        "annual",
        "report",
        "free",
        "charge",
        "upon",
        "request",
        "technology",
        "dermatology",
        "company",
        "focused",
        "identifying",
        "developing",
        "commercializing",
        "branded",
        "generic",
        "topical",
        "drug",
        "product",
        "treatment",
        "skin",
        "disease",
        "current",
        "product",
        "candidate",
        "pipeline",
        "consists",
        "branded",
        "product",
        "candidate",
        "leverage",
        "proprietary",
        "microencapsulation",
        "technology",
        "platform",
        "several",
        "generic",
        "product",
        "candidate",
        "across",
        "multiple",
        "indication",
        "information",
        "please",
        "contact",
        "contact",
        "gilad",
        "mamlok",
        "chief",
        "financial",
        "officer",
        "investor",
        "contact",
        "patricia",
        "bank",
        "westwicke",
        "partner",
        "source",
        "technology",
        "ltd"
    ]
}